Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :29950408
Publication Date : //

Cellular Antisilencing Elements Support Transgene Expression from Herpes Simplex Virus Vectors in the Absence of Immediate Early Gene Expression.


Inactivation of all herpes simplex virus (HSV) immediate early (IE) genes to eliminate vector cytotoxicity results in rapid silencing of the viral genome, similar to the establishment of HSV latency. We recently reported that silencing of a nonviral reporter cassette could be overcome in nonneuronal cells by positioning the cassette in the viral latency (LAT) locus between resident chromatin boundary elements. Here, we tested the abilities of the chicken hypersensitive site 4 insulator and the human ubiquitous chromatin opening element A2UCOE to promote transgene expression from an IE-gene-inactivated HSV vector. We found that A2UCOE was particularly active in nonneuronal cells and reduced reporter promoter occupancy by a repressive histone mark. We determined whether multiple transgenes could be expressed under the control of different promoters from different loci of the same virus. The results showed abundant coexpression of LAT-embedded and A2UCOE-flanked genes in nonneuronal cells. In addition, a third reporter gene without known protective elements was active in cultured rat sensory neurons. These findings indicate that cellular antisilencing sequences can contribute to the expression of multiple genes from separate promoters in fully IE gene-disabled HSV vectors, providing an opportunity for therapeutic applications requiring mutually independent expression of different gene products from a single vector. Gene therapy has now entered a phase of development in which a growing number of recessive single gene defects can be successfully treated by vector-mediated introduction of a wild-type copy of the gene into the appropriate tissue. However, many disease conditions, such as neurodegeneration, cancer, and inflammatory processes, are more complex, requiring either multiple gene corrections or provision of coordinated gene activities to achieve a therapeutic outcome. Although herpes simplex virus (HSV) vectors have the capacity to meet this need, the challenge has been to genetically engineer the HSV genome in a manner to prevent expression of any viral genes while retaining the ability to express multiple therapeutic transgenes under independent transcriptional control. Here, we show that non-HSV insulator elements can be applied to retain at least transient transgene activity from multiple viral loci, thereby opening the door for more complex gene therapy applications in the future.

Authors : Han Fang , Miyagawa Yoshitaka , Verlengia Gianluca , Ingusci Selene , Soukupova Marie , Simonato Michele , Glorioso Joseph C , Cohen Justus B ,

Related products :

Catalog number Product name Quantity
32-166 Plasmid vectors for the expression of coding regions of eukaryotic genes in E. coliare in common usage; such expression vectors often encode hybrid fusion proteins containing part prokaryotic and part 0.1 mg
NB110-57250 Herpes simplex Virus 1 _ HSV1 Immediate Early Protein 0.1 mg
NB110-57252 Herpes simplex Virus 1 _ HSV1 Immediate Early Protein 0.1 mg
NB110-57250 Herpes Simplex Virus 1 (HSV1) Immediate Early Protein 0.1 mg
NB110-57252 Herpes Simplex Virus 1 (HSV1) Immediate Early Protein 0.1 mg
DS-MB-01518 Mouse Anti-Herpes Simplex Virus Type-6 (HSV-6) Human Early Antigen 100
SCH-MPP013 HERPES SIMPLEX VIRUS 2, Product Type Antigen, Specificity HERPES SIMPLEX VIRUS 2, Target Species Viral, Host N_A, Format Inactivated Pathogen, Isotypes , Applications E, Clone 0.2 ml
MPP011 HERPES SIMPLEX VIRUS 1 , Product Type Antigen, Specificity HERPES SIMPLEX VIRUS 1, Target Species Viral, Host N_A, Format Inactivated Pathogen, Isotypes , Applications E, Clone 0.2 ml
SCH-MPP011 HERPES SIMPLEX VIRUS 1 , Product Type Antigen, Specificity HERPES SIMPLEX VIRUS 1, Target Species Viral, Host N_A, Format Inactivated Pathogen, Isotypes , Applications E, Clone 0.2 ml
SCH-MPP010 HERPES SIMPLEX VIRUS 1, Product Type Antigen, Specificity HERPES SIMPLEX VIRUS 1, Target Species Viral, Host N_A, Format Inactivated Pathogen, Isotypes , Applications E, Clone 1 ml
MPP013 HERPES SIMPLEX VIRUS 2, Product Type Antigen, Specificity HERPES SIMPLEX VIRUS 2, Target Species Viral, Host N_A, Format Inactivated Pathogen, Isotypes , Applications E, Clone 0.2 ml
MPP012 HERPES SIMPLEX VIRUS 2, Product Type Antigen, Specificity HERPES SIMPLEX VIRUS 2, Target Species Viral, Host N_A, Format Inactivated Pathogen, Isotypes , Applications E, Clone 1 ml
SCH-MPP012 HERPES SIMPLEX VIRUS 2, Product Type Antigen, Specificity HERPES SIMPLEX VIRUS 2, Target Species Viral, Host N_A, Format Inactivated Pathogen, Isotypes , Applications E, Clone 1 ml
MPP010 HERPES SIMPLEX VIRUS 1, Product Type Antigen, Specificity HERPES SIMPLEX VIRUS 1, Target Species Viral, Host N_A, Format Inactivated Pathogen, Isotypes , Applications E, Clone 1 ml
orb82512 Herpes Simplex Virus-2 (G) protein Herpes Simplex Virus-2 (HSV-2) (G Strain) is an infectious disease antigen_toxin. For research use only. 1 mg
orb82511 Herpes Simplex Virus-1 protein Herpes Simplex Virus-1 (HSV-1) (MacIntyre) is an infectious disease antigen_toxin. For research use only. 1 mg
PIP009 NATIVE HERPES SIMPLEX VIRUS 1 , Product Type Antigen, Specificity HERPES SIMPLEX VIRUS 1, Target Species Viral, Host N_A, Format Inactivated Pathogen, Isotypes , Applications E, Clone 1 ml
SCH-PIP009 NATIVE HERPES SIMPLEX VIRUS 1 , Product Type Antigen, Specificity HERPES SIMPLEX VIRUS 1, Target Species Viral, Host N_A, Format Inactivated Pathogen, Isotypes , Applications E, Clone 1 ml
PIP010 NATIVE HERPES SIMPLEX VIRUS 2 , Product Type Antigen, Specificity HERPES SIMPLEX VIRUS 2, Target Species Viral, Host N_A, Format Inactivated Pathogen, Isotypes , Applications E, Clone 1 ml
SCH-PIP010 NATIVE HERPES SIMPLEX VIRUS 2 , Product Type Antigen, Specificity HERPES SIMPLEX VIRUS 2, Target Species Viral, Host N_A, Format Inactivated Pathogen, Isotypes , Applications E, Clone 1 ml
orb82419 Herpes Simplex Virus-1 protein Herpes Simplex Virus-1 is an infectious disease antigen_toxin. For research use only. 1 mg
PIP029 NATIVE HERPES SIMPLEX VIRUS 2 gG2, Product Type Purified Protein, Specificity HERPES SIMPLEX VIRUS 2 gG2, Target Species Viral, Host N_A, Format Purified, Isotypes , Applications E, Clone 0.2 ml
SCH-MCA404G MOUSE ANTI HERPES SIMPLEX VIRUS 1_2, Product Type Monoclonal Antibody, Specificity HERPES SIMPLEX VIRUS 1_2, Target Species Viral, Host Mouse, Format Purified, Isotypes IgG2a, Applications C, E 1 mg
4955-0304 MOUSE ANTI HERPES SIMPLEX VIRUS 2 gC, Product Type Monoclonal Antibody, Specificity HERPES SIMPLEX VIRUS 2 gC, Target Species Viral, Host Mouse, Format Ascites, Isotypes IgM, Applications IF, C 0.1 ml
SCH-4955-0304 MOUSE ANTI HERPES SIMPLEX VIRUS 2 gC, Product Type Monoclonal Antibody, Specificity HERPES SIMPLEX VIRUS 2 gC, Target Species Viral, Host Mouse, Format Ascites, Isotypes IgM, Applications IF, C 0.1 ml


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur | Gentaur





GENTAUR Ltd.
Unicorn House, Station Cl
Hertfordshire, Potters Bar EN6 1TL
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017
RIB 30004 00187 00010092253 10
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
IBAN FR76 3000 4001 8700 0100 9225 310
france@gentaur.com | Gentaur | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur | Gentaur